Topoisomerase 2β mutation impairs early B-cell development

  • Blood. 2020 Apr 23;135(17):1497-1501. doi: 10.1182/blood.2019003299.
Olivier Papapietro  1  2 Anita Chandra  1  3 Davide Eletto  1 Sarah Inglott  4 Vincent Plagnol  5 James Curtis  1 Mailis Maes  1 Ali Alisaac  1  6 Adriana S Albuquerque  7 Eugenie Basseres  2 Olivier Hermine  8  9 Capucine Picard  9  10  11 Alain Fischer  8  9  11  12 Anne Durandy  8  13 Sven Kracker  8  13 Siobhan O Burns  7  14 Delphine Cuchet-Lourenco  1 Klaus Okkenhaug  3 Sergey Nejentsev  1  2
Affiliations
  • 1. Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • 2. Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  • 3. Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
  • 4. Great Ormond Street Hospital National Health Service Trust, London, United Kingdom.
  • 5. University College London Genetics Institute, London, United Kingdom.
  • 6. College of Applied Sciences, Al Baha University, Al Baha, Saudi Arabia.
  • 7. University College London Institute of Immunity and Transplantation, London, United Kingdom.
  • 8. Imagine Institute, University Paris Descartes Sorbonne Paris Cité, Paris, France.
  • 9. INSERM UMR 1163, Paris, France.
  • 10. Study Center for Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Paris, France.
  • 11. Department of Pediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • 12. Collège de France, Paris, France.
  • 13. Human Lymphohaematopoiesis Laboratory, INSERM UMR 1163, Paris, France; and.
  • 14. Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.